… In our view, in approaching COVID-19 patients, we should … immunoregulatory drugs (targeted
immunotherapy) such as TNF … -inflammatory drugs in COVID-19 patients and to determine …

… review, we summarize the current knowledge of the manifestations of the novel coronaviruses
SARS-CoV, MERS-CoV and COVID-19, … and chemokine immunotherapy may be effective …

… in patients with Covid-19 will pave the way for new treatments and prevention strategies. In
this review, we discuss … In addition, novel immunotherapeutic approaches are presented. …

… in the subgroup of immunotherapy. Therefore, our … of immunotherapy on the development
of severe COVID-19. Recently, Wu et al. observed a higher proportion of severe COVID-19 in …

… Due to the non-availability of any vaccine or drugs against COVID-19, immunotherapies
involving convalescent plasma, immunoglobulins, antibodies (monoclonal or polyclonal), and …

… cancer who are infected with COVID-19. As these efforts are underway, this review aims to
shed light … malignancies being treated with systemic therapies while infected with COVID-19. …

… This review summarizes the current understanding of the immunopathogenesis … review,
we focus on immunological assessment and immunotherapy for patients with severe COVID-19 …

… As in many fields of medical care, the coronavirus disease 2019 (COVID-19) resulted in an
increased uncertainty regarding the safety of allergen immunotherapy (AIT). Therefore, the …

… In this systematic review, we summarize the … COVID-19 and malignant tumors. Using the
PubMed and Scopus databases, we reviewed studies involving cancer therapy and COVID-19 …

… The selection of treatments in this review is based on the 7th edition of the ‘COVID-19 …
COVID-19 patients. Therefore, it could be a potential target for immunotherapy of COVID-19. …